The American Association for Cancer Research (AACR) has honored acclaimed investigator Karen Lu, M.D., chair of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center, as one of the inaugural recipients of the Victoria’s Secret Global Fund for Women’s Cancers 2022 Meritorious Awards, In Partnership with Pelotonia & AACR.
“We are thrilled to see Karen recognized by AACR for her enduring...
The University of Texas MD Anderson Cancer Center applauds the unanimous vote by Houston City Council today to amend the city’s ordinance...
Researchers at The University of Texas MD Anderson Cancer Center have discovered that two distinct classes of cancer-associated fibroblasts...
The University of Texas MD Anderson Cancer Center today launched the James P. Allison Institute, a visionary research and innovation hub within MD Anderson designed to foster groundbreaking science, to develop new treatments and to bring the benefits of immunotherapy to all patients.
The Allison Institute will advance exceptional discovery, translational and clinical research to integrate immunobiology across disciplines and...
A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled...
Neal G. Copeland, Ph.D., and Nancy A. Jenkins, Ph.D., both professors of Genetics at The University of Texas MD Anderson Cancer Center...
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent studies in basic, translational and...
A new computational approach developed by researchers at The University of Texas MD Anderson Cancer Center successfully combines data from...
Results from the ZUMA-12 trial led by researchers at The University of Texas MD Anderson Cancer Center showed that first-line treatment with...
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational...
Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes...